CRS: BJMC
Position: Community Coordinator
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
